1 completed, 1 not yet recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow Community-Acquired Pneumonia (CAP): new trials by email Literature Review of Community-Acquired Pneumonia (CAP) trials Research Report on Community-Acquired Pneumonia (CAP)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multicenter Phase II Trial of NRICM102 Combined With Standard Therapy in Pneumonia NRICM102, Placebo, Intravenous Antibiotic - Mild to Moderate, Community-Acquired Pneumonia (CAP) | Phase 2 | Not yet recruiting | National Research Institute of Chinese Medicine, Ministry of Health and Welfare | 150 | 2026-06-01 | 2026-05-13 |
| Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia Radezolid - Community-Acquired Pneumonia (CAP) | Phase 2 | Completed | Melinta Therapeutics, Inc. | 158 | 2007-10-01 | 2016-05-12 |
Community-Acquired Pneumonia (2)
Community-Acquired Infections (2) · Infections (2) · Pneumonia (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2)
radezolid (1)
Melinta Therapeutics, Inc. (1) · National Research Institute of Chinese Medicine, Ministry of Health and Welfare (1)
Canada (1) · Russia (1) · Taiwan (1) · United States (1)